Dr. Ledermann on Rucaparib Maintenance in Ovarian Cancer | OncLive
Dr. Ledermann on Rucaparib Maintenance in Ovarian Cancer | OncLive
Nov 16, 2017
onclive.com
PARP Inhibitors for BRCA-Mutated Pancreatic Cancer
6:15
PARP Inhibitors for BRCA-Mutated Pancreatic Cancer
81 views6 months ago
YouTubeThe Surgical Scholar
Dr Bryce on the Implications of the Full FDA Approval of Rucaparib in BRCA mCRPC | OncLive
Dr Bryce on the Implications of the Full FDA Approval of Rucaparib in BRCA mCRPC | OncLive
2 months ago
onclive.com
Dr. Coleman on the Effect of Age on Rucaparib Efficacy in Ovarian Cancer | OncLive
Dr. Coleman on the Effect of Age on Rucaparib Efficacy in Ovarian Cancer | OncLive
Mar 17, 2019
onclive.com
Dr. Kristeleit on the Safety Profile of Rucaparib in Ovarian Cancer | OncLive
Dr. Kristeleit on the Safety Profile of Rucaparib in Ovarian Cancer | OncLive
Jan 18, 2017
onclive.com
Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian Cancer | OncLive
Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian Cancer | OncLive
Mar 7, 2020
onclive.com
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
Jul 20, 2017
reachmd.com
3:07
PARP-inhibitors: Mechanism of action
7.1K viewsJun 9, 2019
YouTubeYasser Ali (Elasri1)
11:49
BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI
5.8K viewsJun 1, 2023
YouTubeProstate Cancer Research Institute
Rubraca® (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer
Jan 25, 2021
businesswire.com
Dr Kristeleit on the Implications of Long-Term Data With Rucaparib in Advanced Ovarian Cancer | OncLive
Apr 23, 2024
onclive.com
ルブラカ（ルカパリブ）の副作用、相互作用、用途、薬物の刷り込み - 健康 2026
Aug 22, 2019
oldmedic.com
Dr. Monk on the FDA Approval of Maintenance Rucaparib in Ovarian Cancer | OncLive
Apr 7, 2018
onclive.com
2:06
Rucaparib has high antitumor activity in metastatic, castration-resistant prostate cancer previously treated with taxane-based chemotherapy. Its efficacy without previous chemotherapy is unknown. New research findings are summarized in a short video. https://nej.md/3XMgs85 | The New England Journal of Medicine
1.6K viewsMar 1, 2023
FacebookThe New England Journal of Medicine
ESMO 2024 Insights: Rucaparib /- Nivo as Maintenance in Newly Diagnosed Ovarian Cancer - ATHENA-COMBO Ph3 Trial
355 viewsSep 19, 2024
vumedi.com
FDA grants regular approval to rucaparib for metastatic castration-resistant prostate cancer
4 months ago
marketscreener.com
0:44
Rucaparib recommended for advanced ovarian, fallopian tube & peritoneal cancer after response to first-line platinum-based chemotherapy in final guidance. The at-home tablet treatment is available for eligible NHS patients following chemotherapy response https://www.nice.org.uk/guidance/indevelopment/gid-ta10999/documents?utm_medium=organic&utm_source=facebook&utm_campaign=rucaparib_120325&utm_content=finalvideo | National Institute for Health and Care Excellence
167 viewsMar 12, 2025
FacebookNational Institute for Health and Care Excellence
FDA erteilt reguläre Zulassung für Rucaparib bei metastasiertem kastrationsresistentem Prostatakrebs
4 months ago
marketscreener.com
4:44
Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer
1.6K viewsSep 20, 2022
YouTubeEuropean Society for Medical Oncology (ESMO)
6:49
Platinum-Sensitive Relapsed Ovarian Cancer: Rucaparib
396 viewsJan 12, 2018
YouTubeOncLive
1:04
PARP Inhibitors Antineoplastic Drugs for Cancer
45 views6 months ago
YouTubeDrugs in Motion
3:12
How PARP inhibitors (PARPi) work
29.9K viewsAug 29, 2022
YouTubeHenrik's Lab
1:24
Dr. Coleman on the Effect of Age on the Efficacy of Rucaparib
199 viewsMar 17, 2019
YouTubeOncLive
12:11
PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci
2.5K viewsAug 9, 2018
YouTubeacmedsci
34:17
PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat
9.8K viewsSep 19, 2019
YouTubeUCLA Health
1:41
The Clinical Activity of Rucaparib in Patients With Ovarian Cancer
457 viewsOct 11, 2016
YouTubeTargeted Oncology
3:06
Rucaparib Maintenance Therapy for High-Risk Ovarian Cancer
89 viewsJul 14, 2020
YouTubeTargeted Oncology
Duration of PARP Inhibitor Maintenance Therapy for Ovarian Cancer | OncLive
Oct 7, 2024
onclive.com
11:35
PARP Inhibitors: The Drug That Breaks Cancer's Defense
59 views5 months ago
YouTubeTHE BIOTECH PATH
1:08
Molecular Mechanism of PARP Inhibitor Resistance | Oncoscience
55 viewsSep 26, 2024
YouTubeOncoscience
See more